This page has the following sub pages.
- Part A — Category A assets. Priced stack. Phase-1 on Chart 4. Includes COM Part 13 / EXT-C.4 at $32.5 M. Table 1 lives here.
- Part B — Product layer already on Chart 4. Includes COM Part 21 / EXT-C.5 at $30.0 M.
- Part C — Narrative only. Category B Assets show $0 on Chart 4. Transfer at T1 is not optionality.
- Part D — Chart 4 Grand Total $650 M. Adjacency Maps that must not be read as a second invoice.
- Part E — Registry of Category B assets. One table. Fair value = one Z (Phase-2 Valuation Event) six months after T1. “Combined-with …” (Pairing) sits under that table. Combined-with is Group 1 and Group 2, not Group 2 only.
- Part F — Utilization Matrix [Matrices 1 to 10]: COM (Parts 1 to 23) x Classes I, II, III, V, X. Use, not price. COM x Category B Assets in Z
2012pharmaceutical
sjwilliamspa